This inventor holds 1 USPTO granted patent. Top assignee: Forschungszentrum Julich Gmbh. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Nicolas Chatain: Innovator in Bromodomain Inhibitors
Introduction
Nicolas Chatain is a prominent inventor based in Aachen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of bromodomain inhibitors. His work focuses on creating compounds that can be utilized in the treatment of disorders associated with bromodomains, including cancer.
Latest Patents
Nicolas Chatain holds 1 patent related to his innovative work. His patent, titled "Bromodomain inhibitors," describes compounds according to a specific general formula. These compounds are intended for use in the production of medicaments aimed at treating various disorders linked to bromodomains.
Career Highlights
Nicolas Chatain is affiliated with Forschungszentrum Jülich GmbH, a leading research center in Germany. His role at this institution allows him to collaborate with other experts in the field and contribute to groundbreaking research in medicinal chemistry.
Collaborations
Nicolas has worked alongside talented colleagues, including Jonas Gossen and Bianca Altenburg. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
Nicolas Chatain's work in the field of bromodomain inhibitors showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer and other related disorders.